Cargando…

Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery

PURPOSE: The aim of this study was to understand how coating with a pulmonary surfactant, namely Alveofact, affects the physicochemical parameters as well as in vitro behavior of polyethylenimine (PEI) polyplexes for pulmonary siRNA delivery. METHODS: Alveofact-coated polyplexes were prepared at dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldassi, Domizia, Ngo, Thi My Hanh, Merkel, Olivia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708138/
https://www.ncbi.nlm.nih.gov/pubmed/36447020
http://dx.doi.org/10.1007/s11095-022-03443-3
_version_ 1784840856099880960
author Baldassi, Domizia
Ngo, Thi My Hanh
Merkel, Olivia M.
author_facet Baldassi, Domizia
Ngo, Thi My Hanh
Merkel, Olivia M.
author_sort Baldassi, Domizia
collection PubMed
description PURPOSE: The aim of this study was to understand how coating with a pulmonary surfactant, namely Alveofact, affects the physicochemical parameters as well as in vitro behavior of polyethylenimine (PEI) polyplexes for pulmonary siRNA delivery. METHODS: Alveofact-coated polyplexes were prepared at different Alveofact:PEI coating ratios and analyzed in terms of size, PDI and zeta potential as well as morphology by transmission electron microscopy. The biological behavior was evaluated in a lung epithelial cell line regarding cell viability, cellular uptake via flow cytometry and gene downregulation by qRT-PCR. Furthermore, a 3D ALI culture model was established to test the mucus diffusion and cellular uptake by confocal microscopy as well as gene silencing activity by qRT-PCR. RESULTS: After optimizing the coating process by testing different Alveofact:PEI coating ratios, a formulation with suitable parameters for lung delivery was obtained. In lung epithelial cells, Alveofact-coated polyplexes were well tolerated and internalized. Furthermore, the coating improved the siRNA-mediated gene silencing efficiency. Alveofact-coated polyplexes were then tested on a 3D air-liquid interface (ALI) culture model that, by expressing tight junctions and secreting mucus, resembles important traits of the lung epithelium. Here, we identified the optimal Alveofact:PEI coating ratio to achieve diffusion through the mucus layer while retaining gene silencing activity. Interestingly, the latter underlined the importance of establishing appropriate in vitro models to achieve more consistent results that better predict the in vivo activity. CONCLUSION: The addition of a coating with pulmonary surfactant to polymeric cationic polyplexes represents a valuable formulation strategy to improve local delivery of siRNA to the lungs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11095-022-03443-3.
format Online
Article
Text
id pubmed-9708138
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97081382022-11-30 Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery Baldassi, Domizia Ngo, Thi My Hanh Merkel, Olivia M. Pharm Res Original Research Article PURPOSE: The aim of this study was to understand how coating with a pulmonary surfactant, namely Alveofact, affects the physicochemical parameters as well as in vitro behavior of polyethylenimine (PEI) polyplexes for pulmonary siRNA delivery. METHODS: Alveofact-coated polyplexes were prepared at different Alveofact:PEI coating ratios and analyzed in terms of size, PDI and zeta potential as well as morphology by transmission electron microscopy. The biological behavior was evaluated in a lung epithelial cell line regarding cell viability, cellular uptake via flow cytometry and gene downregulation by qRT-PCR. Furthermore, a 3D ALI culture model was established to test the mucus diffusion and cellular uptake by confocal microscopy as well as gene silencing activity by qRT-PCR. RESULTS: After optimizing the coating process by testing different Alveofact:PEI coating ratios, a formulation with suitable parameters for lung delivery was obtained. In lung epithelial cells, Alveofact-coated polyplexes were well tolerated and internalized. Furthermore, the coating improved the siRNA-mediated gene silencing efficiency. Alveofact-coated polyplexes were then tested on a 3D air-liquid interface (ALI) culture model that, by expressing tight junctions and secreting mucus, resembles important traits of the lung epithelium. Here, we identified the optimal Alveofact:PEI coating ratio to achieve diffusion through the mucus layer while retaining gene silencing activity. Interestingly, the latter underlined the importance of establishing appropriate in vitro models to achieve more consistent results that better predict the in vivo activity. CONCLUSION: The addition of a coating with pulmonary surfactant to polymeric cationic polyplexes represents a valuable formulation strategy to improve local delivery of siRNA to the lungs. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11095-022-03443-3. Springer US 2022-11-29 /pmc/articles/PMC9708138/ /pubmed/36447020 http://dx.doi.org/10.1007/s11095-022-03443-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research Article
Baldassi, Domizia
Ngo, Thi My Hanh
Merkel, Olivia M.
Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title_full Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title_fullStr Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title_full_unstemmed Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title_short Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery
title_sort optimization of lung surfactant coating of sirna polyplexes for pulmonary delivery
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708138/
https://www.ncbi.nlm.nih.gov/pubmed/36447020
http://dx.doi.org/10.1007/s11095-022-03443-3
work_keys_str_mv AT baldassidomizia optimizationoflungsurfactantcoatingofsirnapolyplexesforpulmonarydelivery
AT ngothimyhanh optimizationoflungsurfactantcoatingofsirnapolyplexesforpulmonarydelivery
AT merkeloliviam optimizationoflungsurfactantcoatingofsirnapolyplexesforpulmonarydelivery